BrainStorm Growth, Revenue, Number of Employees and Funding

Overview

Location:
Total Funding:$11.4M
Industry:Tech Services
Founded:1995
Lead Investor(s):Kickstart Seed Fund
Press

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • BrainStorm's estimated revenue is currently $45.4M per year.
  • BrainStorm received $6.4M in venture funding in December 2015.
  • BrainStorm's estimated revenue per employee is $218077
  • BrainStorm's total funding is $11.4M.

Employee Data

  • BrainStorm has 208 Employees.
  • BrainStorm grew their employee count by 2% last year.
  • BrainStorm currently has 2 job openings.

What Is BrainStorm?

BrainStorm enables organizations to do more with their Microsoft technology by making every employee savvy with their software. Adapted to each company and individual user, our on-demand platform, QuickHelp, is engineered to turn education into action by supplying entirely personalized learning experiences. When that happens, you can see real progress in the way you use your tools and start working smarter and faster.

keywords:Human Resources Hr,Telecommunications

208

Number of Employees

$45.4M

Revenue (est)

2

Current Jobs

2%

Employee Growth %

$11.4M

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
SwipeClock
$8.5M85-7%
Eccovia Solutio...
$7.8M804%
Appsbee
$7.9M838%
Executech
$12.8M11613%
AVITRU
$11.8M50-9%
GoReact
$3.8M5028%$14.5M
DirectScale
$6.2M59-16%
Clearview Live
$4M556%
Mozenda
$4.5M5111%
Instasize
$9.2M4316%

BrainStorm News

09/03/2019 - The Vaping-Linked Lung Disease Outbreak Is Getting Serious: Brainstorm Health

Happy Friday, readers! The surge in lung disease cases, and at least five deaths, seemingly linked to vaping products is serious enough that ...

09/08/2019 - BrainStorm Cell Therapeutics to Present Late Breaking News ePoster at the 35th ECTRIMS Congress

NEW YORK, Sept. 06, 2019 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leader in the development of ...

09/03/2019 - BrainStorm Announces Financial Results for the Second Quarter of 2019 and Provides a Corporate Update

13, 2019 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for ...

BrainStorm Funding

DateAmountRoundLead InvestorsReference
2015-12-04$6.4MAKickstart Seed FundArticle